This study will last approximately 19 weeks including 16 infusions total, each one week apart. This is to help patients that have developed Post-Viral Fatigue Syndrome which can include symptoms such as: extreme fatigue, lost of taste, brain fog, and/or seizures.
Randomized, Double Blind, Placebo Controlled, Proof-of-Concept Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post-SARS-CoV-2 Infection.